RxDoctor Payments Data

Andrew French, DO

Family Medicine · Luray, VANPI 1336631472

Payments from drug & device makers

$3,293in general payments, 2019–2025

Across 208 payments — averaging $15.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$438
  • Novo Nordisk$431
  • AbbVie$327
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$292
  • Abbott$166
  • Pfizer$130
  • plus $2K from 33 others

What the payments were for

  • Food & beverage$3,293100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,293 in reported general payments places this provider in the 80th percentile of 2,553 family medicine providers in Virginia.

See all family medicine providers in Virginia

Medicare billing

Part B allowed, 2024
$169,123
Medicare patients
420
Services billed
8,802

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban90$85,401
Trelegy ElliptaFluticasone/Umeclidin/Vilanter91$67,583
XareltoRivaroxaban86$63,520
JardianceEmpagliflozin65$59,181
OxycontinOxycodone Hcl56$50,835
LinzessLinaclotide68$44,886
FarxigaDapagliflozin Propanediol59$44,624
MounjaroTirzepatide42$42,756
TrulicityDulaglutide29$38,404
OzempicSemaglutide32$37,748
RybelsusSemaglutide25$36,137
Breztri AerosphereBudesonide/Glycopyr/Formoterol39$28,794
CreonLipase/Protease/Amylase13$28,675
Spiriva HandihalerTiotropium Bromide36$18,266
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen543$14,267

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta, Incruse Ellipta$57$94,261141 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort, Brilinta$438$90,990140 claims
PfizerEliquis$130$85,40190 claims
Lilly USA, LLCMounjaro, Trulicity$105$81,15971 claims
Boehringer IngelheimJardiance, Combivent Respimat, Spiriva Respimat$24$74,24192 claims
Novo NordiskOzempic, Rybelsus$431$73,88557 claims
AbbVieLinzess, Creon$327$73,56081 claims
Johnson & JohnsonXarelto$46$63,52086 claims
MerckJanuvia$62$10,53912 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,553 family medicine providers in Virginia.

Other family medicine in Luray

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →